Gut microbiota dysfunction in Crohn’s disease
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1540352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Sylvie Buffet-Bataillon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, CHU Rennes, Rennes, France. Hauptthemen laut MEDLINE: Crohn Disease, Gastrointestinal Microbiome, Bacteria. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Crohn’s disease (CD) results from alterations in the gut microbiota and the immune system. However, the exact metabolic dysfunctions of the gut microbiota during CD are still unclear. Here, we investigated metagenomic functions using PICRUSt2 during the course of CD to better understand microbiota-related disease mechanisms and provide new insights for novel therapeutic strategies.
Methods
We performed 16S rRNA-based microbial profiling of 567 faecal samples collected from a cohort of 383 CD patients, including 291 remissions (CR), 177 mild-moderate (CM) and 99 severe (CS) disease states. Gene and pathway composition was assessed using PICRUSt2 analyses of 16S data.
Results
As expected, changes in alpha and beta diversity, in interaction networks and increases in Proteobacteria abundance were associated with disease severity. However, microbial function was more consistently disrupted than composition from CR, to CM and then to CS. Major shifts in oxidative stress pathways and reduced carbohydrate and amino acid metabolism in favour of nutrient transport were identified in CS compared to CR. Virulence factors involved in host invasion, host evasion and inflammation were also increased in CS.
Conclusions
This functional metagenomic information provides new insights into community-wide microbial processes and pathways associated with CD pathogenesis. This study paves the way for new advanced strategies to rebalance gut microbiota and/or eliminate oxidative stress, and biofilm to downregulate gut inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Microbiology, CHU Rennes, Rennes, France.
- Institut NUMECAN, INRAE, INSERM, Univ Rennes, Rennes, France.
- Université Paris-Saclay, INRAE, MaIAGE, Jouy-en-Josas, France.
- Université Paris-Saclay, INRAE, BioinfOmics, MIGALE Bioinformatics Facility, Jouy-en-Josas, France.
- IRISA, Univ Rennes, Inria, CNRS, Rennes, France.
- CHU Rennes, Univ Rennes, INSERM, U1230, Rennes, France.
Zitieren
APA
Buffet-Bataillon, S., Durão, G., Le Huërou-Luron, I., Rué, O., Le Cunff, Y., Cattoir, V., & Bouguen, G. (2025). Gut microbiota dysfunction in Crohn’s disease. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1540352
Vancouver
Buffet-Bataillon S, Durão G, Le Huërou-Luron I, Rué O, Le Cunff Y, Cattoir V, et al. Gut microbiota dysfunction in Crohn’s disease. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1540352
BibTeX
@article{BuffetBataillon2025,
author = {Buffet-Bataillon, Sylvie and Durão, Gabriela and Le Huërou-Luron, Isabelle and Rué, Olivier and Le Cunff, Yann and Cattoir, Vincent and Bouguen, Guillaume},
title = {Gut microbiota dysfunction in Crohn’s disease},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1540352}
}
EUVIMED